Best in Biotech 22 Aug 2024 Seven companies transforming the biotech industry in Italy Delve into Italy’s biotech landscape with seven companies that are leading the charge in the European country. August 22, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 21 Aug 2024 The promise of antisense oligonucleotides in precision medicine Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases. August 21, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Aug 2024 Fighting mpox: promising vaccines to watch As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak. August 20, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 16 Aug 2024Challenging the European biotech funding status quo Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin. August 16, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 15 Aug 2024 10 neuroscience biotech companies you should know about Learn more about nine of the top neuroscience biotech companies looking to develop treatments for difficult-to-treat neurological conditions. August 15, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Aug 2024 CAR-T drugs and parkinsonism: a cause for concern? CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt. August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Aug 2024 Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry? Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug. August 13, 2024 - 4 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 Aug 2024 The therapeutic potential of circular RNA: Could it soon trump mRNA technology? Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies. August 9, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 9 Aug 2024Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi. August 9, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 6 Aug 2024 The biggest private biotech investments in July 2024 The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024. August 6, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Aug 2024 Six epigenetics companies making strides in 2024 In this article, we take a look at six epigenetics companies that are significant as well as up-and-coming players in the industry. August 2, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 2 Aug 2024Rebroadcast: How does AI assist drug discovery? Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS. August 2, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More